NOTCH3 and pulmonary arterial hypertension: Giving the fact that enhanced Notch3 signaling is associated with the pulmonary vascular remodeling in clinic patients and a variety of animal model of PAH, the strategy that interfering Notch3 signaling pathway might prevent or treat the development of PAH, it is worthy to test the effect and safety of this approach in clinic patients with PAH.